Evaluation of octamethylcyclotetrasiloxane (D4) as an inducer of rat hepatic microsomal cytochrome P450, UDP-glucuronosyltransferase, and epoxide hydrolase: a 28-day inhalation study.

Repeated inhalation exposure to octamethylcyclotetrasiloxane (D4) produces a reversible and dose-related hepatomegaly and proliferation of hepatic endoplasmic reticulum in rats. However, the effects of D4 on the expression of cytochrome P450 enzymes have not been evaluated. In the present study, the time course for changes in hepatic microsomal cytochrome P450 enzyme expression following repeated inhalation exposure to D4 vapors was determined in male and female Fischer 344 rats. Animals were exposed to D4 vapor at concentrations of 70 and 700 ppm, via whole body inhalation for 6 h/day, 5 days/week for 4 weeks. Specified animals were euthanized on exposure days 3, 7, 14, 21, and 28. Microsomal fractions were prepared from fresh liver by differential centrifugation. Enzyme activity as well as immunoreactive protein levels of several cytochrome P450 enzymes (CYP), epoxide hydrolase, and UDP-glucuronosyltransferase (UDPGT) were evaluated. The time course for enzyme induction was monitored by measuring 7-ethoxyresorufin O-deethylase (EROD) and 7-pentoxyresorufin O-depentylase (PROD) activities on days 3, 7, 14, 21, and 28. CYP1A1/2 activity, as determined by EROD activity, was increased approximately 2- to 3-fold over the exposure period. However, an examination of immunoreactive protein revealed no induction of CYP1A1 and a suppression of CYP1A2 in the 700 ppm D4 group. In comparison, CYP2B1/2 enzyme activity, as determined by PROD, was significantly increased as early as day 3 in both the 70 and 700 ppm D4 groups of male and female rats. Overall, PROD activity on day 28 was induced more than 10-fold in the 70 ppm D4 groups and more than 20-fold in the 700 ppm D4 groups. The increase in PROD activity was paralleled by a comparable increase in CYP2B1/2 immunoreactive protein. There was a modest (2- to 3-fold) increase in CYP3A1/2 activity and immunoreactive protein, as determined by 6 beta-hydroxylation of testosterone and Western blot analysis. Expression of CYP enzymes was at or near maximum by day 14 and remained relatively constant throughout the exposure period. On day 28, epoxide hydrolase activity and immunoreactive protein were induced (2- to 3-fold) in a dose-dependent manner. Only slight changes in the expression and activity of UDPGT were detected, and these did not appear to be dose related. Thus, repeated inhalation exposure to D4 induces CYP enzymes and epoxide hydrolase in a manner similar to that observed for phenobarbital (PB). Therefore, D4 can be described as a "PB-like" inducer of hepatic microsomal enzymes in the Fischer 344 rat.

[1]  J. Hamelink,et al.  Effects of octamethylcyclotetrasiloxane (OMCTS) on freshwater and marine organisms , 1995 .

[2]  G. Siest,et al.  UDP-glucuronosyltransferase activities. Guidelines for consistent interim terminology and assay conditions. , 1983, Biochemical pharmacology.

[3]  W. H. Butler Long-term effects of phenobarbitone-Na on male Fischer rats. , 1978, British Journal of Cancer.

[4]  A. Y. Lu,et al.  Partial purification of cytochromes P-450 and P-448 from rat liver microsomes. , 1972, Biochemical and biophysical research communications.

[5]  G. Thompson,et al.  Safety assessment of OTC drugs: doxylamine succinate. , 1995, Archives of toxicology. Supplement. = Archiv fur Toxikologie. Supplement.

[6]  L. Young,et al.  Toxicology: The Basic Science of Poisons , 1976 .

[7]  R. Mayer,et al.  Direct fluorometric methods for measuring mixed function oxidase activity. , 1978, Methods in enzymology.

[8]  M. P. Arlotto,et al.  Purification of two isozymes of rat liver microsomal cytochrome P450 with testosterone 7 alpha-hydroxylase activity. , 1989, Archives of biochemistry and biophysics.

[9]  P. Chand,et al.  Enzymatic digestion, solid-phase extraction, and gas chromatography/mass spectrometry of derivatized intact oxazepam in urine. , 1991, Clinical chemistry.

[10]  J. Ward,et al.  Lack of effect of phenobarbital on hepatocellular carcinogenesis initiated by N-nitrosodiethylamine or methylazoxymethanol acetate in male Syrian golden hamsters. , 1986, Toxicology and applied pharmacology.

[11]  J. O. Nelson,et al.  Induction of hepatic cytochrome P-450 mediated alkoxyresorufin O-dealkylase activities in different species by prototype P-450 inducers. , 1990, Chemico-biological interactions.

[12]  M. P. Arlotto,et al.  Digitoxin metabolism by liver microsomal cytochrome P-450 and UDP-glucuronosyltransferase and its role in the protection of rats from digitoxin toxicity by pregnenolone-16 alpha-carbonitrile. , 1986, Archives of biochemistry and biophysics.

[13]  T. Omura,et al.  THE CARBON MONOXIDE-BINDING PIGMENT OF LIVER MICROSOMES. I. EVIDENCE FOR ITS HEMOPROTEIN NATURE. , 1964, The Journal of biological chemistry.

[14]  L J LEACH,et al.  An animal inhalation exposure unit for toxicity screening. , 1958, American Industrial Hygiene Association journal.

[15]  R. Mayer,et al.  Ethoxy-, pentoxy- and benzyloxyphenoxazones and homologues: a series of substrates to distinguish between different induced cytochromes P-450. , 1985, Biochemical pharmacology.

[16]  U. K. Laemmli,et al.  Cleavage of structural proteins during , 1970 .

[17]  G. Williams CLASSIFICATION OF GENOTOXIC AND EPIGENETIC HEPATOCARCINOGENS USING LIVER CULTURE ASSAYS * , 1980, Annals of the New York Academy of Sciences.

[18]  S. Varaprath,et al.  Fate of silicone degradation products (silanols) in soil , 1994 .

[19]  B. Hammock,et al.  Radiometric assays for mammalian epoxide hydrolases and glutathione S-transferase. , 1983, Analytical biochemistry.

[20]  D. Giera,et al.  A convenient method for the determination of hepatic lauric acid omega-oxidation based on solvent partition. , 1991, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[21]  M W Linder,et al.  Developmental aspects of glucocorticoid regulation of polycyclic aromatic hydrocarbon-inducible enzymes in rat liver. , 1993, Archives of biochemistry and biophysics.

[22]  References , 1971 .

[23]  H. Wortelboer,et al.  Interlaboratory comparison of microsomal ethoxyresorufin and pentoxyresorufin O-dealkylation determinations: standardization of assay conditions , 2006, Archives of Toxicology.

[24]  R. Weaver,et al.  Cytochrome P450 specificities of alkoxyresorufin O-dealkylation in human and rat liver. , 1994, Biochemical pharmacology.

[25]  P. Thomas,et al.  Induction of two immunochemically related rat liver cytochrome P-450 isozymes, cytochromes P-450c and P-450d, by structurally diverse xenobiotics. , 1983, The Journal of biological chemistry.

[26]  J. Ward,et al.  A pleiotropic response to phenobarbital-type enzyme inducers in the F344/NCr rat. Effects of chemicals of varied structure. , 1992, Biochemical pharmacology.

[27]  A. Parkinson,et al.  Pronounced and differential effects of ionic strength and pH on testosterone oxidation by membrane-bound and purified forms of rat liver microsomal cytochrome P-450. , 1990, Journal of steroid biochemistry.

[28]  P. Lietman,et al.  Chloramphenicol glucuronyl transferase: assay, ontogeny and inducibility. , 1978, The Journal of pharmacology and experimental therapeutics.

[29]  H. Towbin,et al.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[30]  M. Cayen,et al.  Evaluation of loratadine as an inducer of liver microsomal cytochrome P450 in rats and mice. , 1992, Biochemical pharmacology.

[31]  G. Williams,et al.  Phenobarbital mechanistic data and risk assessment: enzyme induction, enhanced cell proliferation, and tumor promotion. , 1996, Pharmacology & therapeutics.

[32]  J. Olsen,et al.  Phenobarbital, drug metabolism, and human cancer. , 1993, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[33]  J. Olsen,et al.  Cancer in children of epileptic mothers and the possible relation to maternal anticonvulsant therapy. , 1990, British Journal of Cancer.

[34]  P. K. Smith,et al.  Measurement of protein using bicinchoninic acid. , 1985, Analytical biochemistry.

[35]  A. Isquith,et al.  Genotoxicity studies on selected organosilicon compounds: in vitro assays. , 1988, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[36]  E. Schuetz,et al.  Differentiated induction of cytochrome P450b/e and P450p mRNAs by dose of phenobarbital in primary cultures of adult rat hepatocytes. , 1990, Molecular pharmacology.

[37]  A. Walker,et al.  The toxicology of dieldrin (HEOD). II. Comparative long-term oral toxicity studies in mice with dieldrin, DDT, phenobarbitone, -BHC and -BHC. , 1973, Food and cosmetics toxicology.

[38]  M. P. Arlotto,et al.  Regulation of testosterone hydroxylation by rat liver microsomal cytochrome P-450. , 1987, Archives of biochemistry and biophysics.

[39]  J. Olsen,et al.  Cancer among epileptic patients exposed to anticonvulsant drugs. , 1989, Journal of the National Cancer Institute.

[40]  A. Parkinson,et al.  Effects of freezing, thawing, and storing human liver microsomes on cytochrome P450 activity. , 1996, Archives of biochemistry and biophysics.

[41]  J. Hobson Existing chemical testing for environmental fate and effects under TSCA section 4 : a case study with octamethylcyclotetrasiloxane (OMCTS) , 1995 .

[42]  A. Parkinson,et al.  Production and purification of antibodies against rat liver P450 enzymes. , 1991, Methods in enzymology.

[43]  D. D. Toro,et al.  Fate of octamethylcyclotetrasiloxane (OMCTS) in the atmosphere and in sewage treatment plants as an estimation of aquatic exposure , 1995 .

[44]  Deborah A. Hartley,et al.  Bioconcentration by fish of a highly volatile silicone compound in a totally enclosed aquatic exposure system , 1995 .

[45]  P. Thomas,et al.  Comparative pharmacodynamics of CYP2B induction by phenobarbital in the male and female F344/NCr rat. , 1993, Biochemical pharmacology.

[46]  K. Straub,et al.  Determination of microsomal lauric acid hydroxylase activity by HPLC with flow-through radiochemical quantitation , 1988, Analytical Biochemistry.

[47]  R. Fessenden,et al.  Metabolic fate of phenyltrimethylsilane and phenyldimethylsilane. , 1970, Journal of medicinal chemistry.

[48]  A. Parkinson,et al.  Reduction of 7-alkoxyresorufins by NADPH-cytochrome P450 reductase and its differential effects on their O-dealkylation by rat liver microsomal cytochrome P450. , 1989, Archives of biochemistry and biophysics.

[49]  M. McKenna,et al.  Improved methodology for generating controlled test atmospheres. , 1980, American Industrial Hygiene Association journal.

[50]  O. Pelkonen Biotransformation of xenobiotics in the fetus. , 1980, Pharmacology & therapeutics.

[51]  J. Goldstein,et al.  Induction of specific cytochrome P-450 isozymes by methylenedioxyphenyl compounds and antagonism by 3-methylcholanthrene. , 1985, Archives of biochemistry and biophysics.

[52]  R. B. Annelin,et al.  The piscine bioconcentration characteristics of cyclic and linear oligomeric permethylsiloxanes. , 1989, The Science of the total environment.

[53]  B. Hammock,et al.  Epoxide hydrolases in the catabolism of sterols and isoprenoids. , 1985, Methods in enzymology.

[54]  M. Cunningham,et al.  Biochemical effects of the mouse hepatocarcinogen oxazepam: similarities to phenobarbital. , 1996, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[55]  W. Hauser,et al.  Cancer incidence in a cohort of patients with seizure disorders. , 1986, Journal of the National Cancer Institute.

[56]  A. H. Phillips,et al.  Hepatic triphosphopyridine nucleotide-cytochrome c reductase: isolation, characterization, and kinetic studies. , 1962, The Journal of biological chemistry.

[57]  R. Branch,et al.  The relationship between liver volume, antipyrine clearance and indocyanine green clearance before and after phenobarbitone administration in man. , 1976, British journal of clinical pharmacology.

[58]  M. T. Donato,et al.  Effect of xenobiotics on monooxygenase activities in cultured human hepatocytes. , 1990, Biochemical pharmacology.

[59]  J. W. Cameron,et al.  Dealkylation of pentoxyresorufin: a rapid and sensitive assay for measuring induction of cytochrome(s) P-450 by phenobarbital and other xenobiotics in the rat. , 1985, Archives of biochemistry and biophysics.

[60]  J. Clemmesen,et al.  Is phenobarbital carcinogenic? A follow-up of 8078 epileptics. , 1978, Ecotoxicology and environmental safety.